Top Preclinical Cro Companies in Japan

Linical is dedicated to enhancing the clinical development process, providing tailored solutions that can help overcome challenges and expedite timelines, ultimately contributing to successful clinical trials. Their expertise and commitment to patient impact position them as a valuable partner in the preclinical and clinical research landscape.

REPROCELL offers a comprehensive range of services and products that support translational research, including expertise in stem cell research and preclinical drug discovery. Their capabilities extend to providing induced pluripotent stem cells (iPSCs) and conducting clinical trials, making them a valuable resource for advancing therapies.

The company, 株式会社 新日本科学, specializes in preclinical services, offering extensive support for the development of pharmaceuticals, medical devices, and regenerative medicine products through essential preclinical testing. Their commitment to advancing drug development and medical technology underscores their role in addressing patient needs.

SMC is a Global Specialty CRO that focuses on non-clinical studies, offering expertise in liver cancer assessment through its STAM™ model, which effectively mimics human disease progression. This makes it a valuable resource for preclinical liver cancer research.

Shanghai Medicilon Biomedicine, a leading preclinical CRO in China, offers comprehensive support for drug development, including over 300 cancer transplant models and various assay techniques to measure critical biomarkers. Their services facilitate efficacy testing for advanced therapies like CAR-T and antibodies.

The company, Agatha Life, offers ready-to-use software applications specifically designed for clinical operations, which can significantly accelerate and enhance the management of clinical trials and related processes. Their focus on improving clinical and compliance workflows ensures that essential documents are effectively managed, addressing the urgent needs of life science organizations.

PhoenixBio has developed a chimeric mouse model with a humanized liver, enhancing the translational relevance of preclinical drug testing. This innovative model, along with freshly isolated primary human hepatocytes, provides valuable insights into human outcomes, making it a crucial tool for advancing drug discovery and development projects.

The company, RealCRO, is a multilingual promotional marketing agency in Japan that focuses on helping brands achieve their growth ambitions through integrated marketing communications services.

The company leverages over 1 billion proprietary biopharmaceutical data points and advanced AI technology to identify valuable antibodies and peptides, which is crucial for preclinical research. Their capabilities include directed evolution experiments and machine learning models that predict essential biopharmaceutical properties.

Pathology Associates specializes in providing equity and credit analysis of life science companies, utilizing forensic analysis of clinical data and proprietary AI-assisted modeling. Their focus on continuous improvement ensures that their content remains compliant with current standards, making them a relevant resource for investors interested in preclinical developments in the bioscience sector.